首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1339241

糖尿病视网膜病变市场、份额、市场规模、趋势、产业分析报告：按类型、按管理方法、按地区、细分市场趋势，2023-2032

Diabetic Retinopathy Market Share, Size, Trends, Industry Analysis Report, By Type (Proliferative DR, Non-proliferative DR); By Management (Intraocular Steroid Injection, Laser Surgery, Vitrectomy); By Region, And Segment Forecasts, 2023 - 2032

出版日期: 2023年07月23日 | 出版商:

Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

根据Polaris Market Research的最新研究，到2032年，全球糖尿病视网膜病变市场规模预计将达到152.3亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

糖尿病的盛行率正在显着增加，对全球健康产生重大影响。根据国际糖尿病联盟的数据，2021年患有糖尿病的人数约为5.37亿人。预计到 2030 年，这一数字将增加至 6.43 亿，到 2045 年将达到惊人的 7.83 亿。糖尿病被认为是全世界失明的主要原因之一。

糖尿病引起的失明通常是由于视网膜血管渗漏或破裂造成的损伤造成的。视力丧失的程度各不相同，从永久性到暂时性损害不等，取决于疾病的阶段。一项研究显示，预计2020年，糖尿病视网膜病变（一种由糖尿病引起的视力损害）患者数量将约为1.0312亿。预计到 2045 年，这一数字将增加至约 1.605 亿。

高龄化社会在医疗保健需求方面提出了独特的挑战，包括糖尿病等慢性病盛行率的增加。由于医疗进步和预期寿命的提高，预计 65 岁及以上的人口数量将大幅增加。例如，根据人口研究所的《美国老化》报告，美国65岁及以上的人口预计将从2016年的约4,600万增加到2060年的9,800万以上。

这种人口结构的变化强调了解决与老化相关的健康问题（包括糖尿病视网膜病变）的重要性。医疗保健提供者和市场製造商必须做好准备，以满足不断增长的人口不断增长的需求，并提供有效的解决方案来管理糖尿病视网膜病变和保护老年人的视力。

COVID-19 大流行对世界各地的医疗保健系统产生了重大影响，包括糖尿病视网膜病变的诊断和治疗。糖尿病视网膜病变的早期检测和治疗指南受到大流行期间施加的约束和限制的显着影响。玻璃体内注射是糖尿病视网膜病变的常见治疗方法，与 2019 年相比，疫情期间全球使用量显着下降。减少率各不相同，但范围从大约 30% 到超过 100%。

糖尿病视网膜病变市场报告亮点

由于糖尿病患者数量不断增加，非增殖性糖尿病视网膜病变细分市场将在 2022 年占据全球最高市场份额

抗VEGF药物由于疗效高、治疗演算法好，占最大份额

由于庞大的未开发人口和不断提高的患者意识，亚太地区正在以最快的速度增长

糖尿病视网膜病变市场 - 产业概况
糖尿病视网膜病变市场动态
- 推动者和机会
  - 糖尿病盛行率不断上升，糖尿病导致的失明率不断上升
  - 提高对糖尿病护理和管理以及新产品发布的认识
- 抑制因素和挑战
  - 成本高
杵分析
糖尿病视网膜病变的产业趋势
价值链分析
COVID-19 感染的影响分析

第 5 章全球糖尿病视网膜病变市场（依类型）

主要发现
简介
增殖性糖尿病视网膜病变
非增殖性糖尿病视网膜病变

第 6 章全球糖尿病视网膜病变市场（依管理方法）

主要发现
简介
抗 VEGF
眼内类固醇注射
雷射手术
玻璃体手术

第 7 章全球糖尿病视网膜病变市场（按地区）

主要发现
简介
- 2019-2032 年糖尿病视网膜病变市场评估（按地区）
糖尿病视网膜病变市场 - 北美
- 北美：糖尿病视网膜病变市场，依管理方式划分，2019-2032 年
- 北美：2019-2032 年糖尿病视网膜病变市场（依类型）
- 糖尿病视网膜病变市场 - 美国
- 糖尿病视网膜病变市场 - 加拿大
糖尿病视网膜病变市场 - 欧洲
- 欧洲：糖尿病视网膜病变市场，依管理方式划分，2019-2032 年
- 欧洲：糖尿病视网膜病变市场（按类型），2019-2032 年
- 糖尿病视网膜病变市场 - 英国
- 糖尿病视网膜病变市场 - 法国
- 糖尿病视网膜病变市场 - 德国
- 糖尿病视网膜病变市场 - 义大利
- 糖尿病视网膜病变市场 - 西班牙
- 糖尿病视网膜病变市场 - 荷兰
- 糖尿病视网膜病变市场 - 俄罗斯
糖尿病视网膜病变市场 - 亚太地区
- 亚太地区：糖尿病视网膜病变市场，依管理方式划分，2019-2032 年
- 亚太地区：2019-2032 年糖尿病视网膜病变市场（依类型）
- 糖尿病视网膜病变市场 - 中国
- 糖尿病视网膜病变市场 - 印度
- 糖尿病视网膜病变市场 - 马来西亚
- 糖尿病视网膜病变市场 - 日本
- 糖尿病视网膜病变市场 - 印度尼西亚
- 糖尿病视网膜病变市场 - 韩国
糖尿病视网膜病变市场 - 中东和非洲
- 中东和非洲：糖尿病视网膜病变市场（按管理方法），2019-2032 年
- 中东和非洲：2019-2032 年糖尿病视网膜病变市场（按类型）
- 糖尿病视网膜病变市场 - 沙乌地阿拉伯
- 糖尿病视网膜病变市场 - 阿拉伯联合大公国
- 糖尿病视网膜病变市场 - 以色列
- 糖尿病视网膜病变市场 - 南非
糖尿病视网膜病变市场 - 拉丁美洲
- 拉丁美洲：糖尿病视网膜病变市场，依管理方式划分，2019-2032 年
- 拉丁美洲：2019-2032 年糖尿病视网膜病变市场（依类型）
- 糖尿病视网膜病变市场 - 墨西哥
- 糖尿病视网膜病变市场 - 巴西
- 糖尿病视网膜病变市场 - 阿根廷

第八章竞争态势

扩张与收购分析
- 放大
- 收购
伙伴关係/协作/协议/揭露

第九章公司简介

Bayer
Allergan
Novartis
Oxurion
Sirnaomics
Genentech
Alimera Sciences
Ampio Pharmaceuticals
BCN Peptides
Kowa Company

简介目录图表

Product Code: PM3621

The global diabetic retinopathy market size is expected to reach USD 15.23 billion by 2032, according to a new study by Polaris Market Research. The report "Diabetic Retinopathy Market Share, Size, Trends, Industry Analysis Report, By Type (Proliferative DR, Non-proliferative DR); By Management (Intraocular Steroid Injection, Laser Surgery, Vitrectomy); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The incidence of diabetes has been witnessing a significant surge, with a substantial impact on global health. According to the International Diabetes Federation, the number of individuals affected by diabetes was approximately 537 million in 2021. This figure is projected to increase to 643 million by 2030 and a staggering 783 million by 2045. Diabetes is recognized as one of the leading causes of blindness worldwide.

Blindness in individuals with diabetes is often attributed to the damage caused by leaking or ruptured blood vessels in the retina. The severity of vision loss can vary, ranging from permanent impairment to temporary disruptions depending on the stage of the disease. Research indicates that the number of cases of diabetic retinopathy, a specific form of vision impairment associated with diabetes, was estimated to be around 103.12 million in 2020. It is anticipated that the number of cases will escalate to approximately 160.5 million by 2045.

The aging population presents unique challenges in terms of healthcare needs, including a higher prevalence of chronic diseases like diabetes. With advancements in medical care and improved life expectancy, the number of individuals aged 65 years and over is projected to escalate substantially. For instance, the "Aging in the United States" report by the Population Reference Bureau indicates that the population of individuals aged 65 years and above in the U.S. is estimated to grow from approximately 46 million in 2016 to over 98 million by the year 2060.

This demographic shift underscores the importance of addressing health issues associated with aging, including diabetic retinopathy. Healthcare providers and manufacturers in the market must be prepared to meet the growing demands of this expanding population and provide effective solutions to manage diabetic retinopathy and preserve vision in older adults.

The COVID-19 pandemic had a substantial impact on healthcare systems worldwide, including the diagnosis and treatment of diabetic retinopathy. Due to the constraints and restrictions imposed during the pandemic, early detection and treatment guidelines for diabetic retinopathy were significantly affected. Intravitreal injections, which are a common treatment modality for diabetic retinopathy, experienced a significant decrease in usage globally during the pandemic compared to 2019. Reduction percentages varied but ranged from approximately 30% to over 100%.

Diabetic Retinopathy Market Report Highlights

Non-proliferative diabetic retinopathy segment accounted for highest global market share in 2022, due to rise in number of cases of diabetes

Anti-VEGF segment accounted largest share, due its high efficacy and better treatment algorithm

Asia Pacific region grown at the fastest rate, owing huge un-tapped population and better patient awareness

The global key market players include: Bayer, Allergan, Novartis, Oxurion, Sirnaomics, Genentech, Alimera Sciences, Ampio Pharmaceuticals, BCN Peptides, and Kowa Company.

Polaris Market Research has segmented the diabetic retinopathy market report based on type, management, and region:

Diabetic Retinopathy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Proliferative Diabetic Retinopathy
Non-proliferative diabetic retinopathy

Diabetic Retinopathy, Management Outlook (Revenue - USD Billion, 2019 - 2032)

Anti-VEGF
Intraocular Steroid Injection
Laser Surgery
Vitrectomy

Diabetic Retinopathy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diabetic Retinopathy Market Insights

4.1. Diabetic Retinopathy Market - Industry Snapshot
4.2. Diabetic Retinopathy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of diabetes and increasing prevalence of blindness due to diabetes
  - 4.2.1.2. Growing awareness about diabetes care and management and new product launches
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Diabetic Retinopathy Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Diabetic Retinopathy Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diabetic Retinopathy, by Type, 2019-2032 (USD Billion)
5.3. Proliferating Diabetic retinopathy
- 5.3.1. Global Diabetic Retinopathy Market, by Proliferating Diabetic retinopathy, by Region, 2019-2032 (USD Billion)
5.4. Non proliferating Diabetic Retinopathy
- 5.4.1. Global Diabetic Retinopathy Market, by Non proliferating Diabetic Retinopathy, by Region, 2019-2032 (USD Billion)

6. Global Diabetic Retinopathy Market, by Management

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
6.3. Anti VEGF
- 6.3.1. Global Diabetic Retinopathy Market, by Anti VEGF, by Region, 2019-2032 (USD Billion)
6.4. Intraocular Steroid Injection
- 6.4.1. Global Diabetic Retinopathy Market, by Intraocular Steroid Injection, by Region, 2019-2032 (USD Billion)
6.4. Laser Surgery
- 6.4.1. Global Diabetic Retinopathy Market, by Laser Surgery, by Region, 2019-2032 (USD Billion)
6.5. Vitrectomy
- 6.5.1. Global Diabetic Retinopathy Market, by Vitrectomy, by Region, 2019-2032 (USD Billion)

7. Global Diabetic Retinopathy Market, by Geography

7.1. Key findings
7.2. Introduction
- 7.2.1. Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
7.3. Diabetic Retinopathy Market - North America
- 7.3.1. North America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.3.2. North America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.3.3. Diabetic Retinopathy Market - U.S.
  - 7.3.3.1. U.S.: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.3.3.2. U.S.: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.3.4. Diabetic Retinopathy Market - Canada
  - 7.3.4.1. Canada: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.3.4.2. Canada: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.4. Diabetic Retinopathy Market - Europe
- 7.4.1. Europe: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.4.2. Europe: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.3. Diabetic Retinopathy Market - UK
  - 7.4.3.1. UK: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.3.2. UK: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.4. Diabetic Retinopathy Market - France
  - 7.4.4.1. France: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.4.2. France: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.5. Diabetic Retinopathy Market - Germany
  - 7.4.5.1. Germany: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.5.2. Germany: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.6. Diabetic Retinopathy Market - Italy
  - 7.4.6.1. Italy: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.6.2. Italy: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.7. Diabetic Retinopathy Market - Spain
  - 7.4.7.1. Spain: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.7.2. Spain: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.8. Diabetic Retinopathy Market - Netherlands
  - 7.4.8.1. Netherlands: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.8.2. Netherlands: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.9. Diabetic Retinopathy Market - Russia
  - 7.4.9.1. Russia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.9.2. Russia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.5. Diabetic Retinopathy Market - Asia Pacific
- 7.5.1. Asia Pacific: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.3. Diabetic Retinopathy Market - China
  - 7.5.3.1. China: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.3.2. China: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.4. Diabetic Retinopathy Market - India
  - 7.5.4.1. India: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.4.2. India: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.5. Diabetic Retinopathy Market - Malaysia
  - 7.5.5.1. Malaysia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.5.2. Malaysia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.6. Diabetic Retinopathy Market - Japan
  - 7.5.6.1. Japan: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.6.2. Japan: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.7. Diabetic Retinopathy Market - Indonesia
  - 7.5.7.1. Indonesia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.7.2. Indonesia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.8. Diabetic Retinopathy Market - South Korea
  - 7.5.8.1. South Korea: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.8.2. South Korea: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.6. Diabetic Retinopathy Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.3. Diabetic Retinopathy Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.4. Diabetic Retinopathy Market - UAE
  - 7.6.4.1. UAE: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.4.2. UAE: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.5. Diabetic Retinopathy Market - Israel
  - 7.6.5.1. Israel: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.5.2. Israel: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.6. Diabetic Retinopathy Market - South Africa
  - 7.6.6.1. South Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.6.2. South Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.7. Diabetic Retinopathy Market - Latin America
- 7.7.1. Latin America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.3. Diabetic Retinopathy Market - Mexico
  - 7.7.3.1. Mexico: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.3.2. Mexico: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.4. Diabetic Retinopathy Market - Brazil
  - 7.7.4.1. Brazil: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.4.2. Brazil: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.5. Diabetic Retinopathy Market - Argentina
  - 7.7.5.1. Argentina: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.5.2. Argentina: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Bayer
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Allergan
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Novartis
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Oxurion
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Sirnaomics
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Genentech
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Alimera Sciences
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Ampio Pharmaceuticals
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. BCN Peptides
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Kowa Company
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development

简介目录图表

List of Tables

Table 1 Global Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 2 Global Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 3 Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 4 North America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 5 North America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 6 U.S.: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 7 U.S.: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 8 Canada: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 9 Canada: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 10 Europe: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 11 Europe: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 12 UK: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 13 UK: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 14 France: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 15 France: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 16 Germany: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 17 Germany: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 18 Italy: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 19 Italy: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 20 Spain: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 21 Spain: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 22 Netherlands: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 23 Netherlands: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 24 Russia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 25 Russia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 26 Asia Pacific: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 27 Asia Pacific: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 28 China: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 29 China: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 30 India: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 31 India: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 32 Malaysia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 33 Malaysia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 34 Japan: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 35 Japan: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 36 Indonesia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 37 Indonesia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 38 South Korea: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 39 South Korea: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 40 Middle East & Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 41 Middle East & Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 42 Saudi Arabia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 43 Saudi Arabia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 44 UAE: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 45 UAE: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 46 Israel: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 47 Israel: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 48 South Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 49 South Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 50 Latin America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 51 Latin America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 52 Mexico: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 53 Mexico: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 54 Brazil: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 55 Brazil: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 56 Argentina: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 57 Argentina: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)

List of Figures

Figure 1 Global Diabetic Retinopathy Market, 2019-2032 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Management
Figure 7 Global Diabetic Retinopathy Market, by Management, 2022 & 2032 (USD Billion)
Figure 8 Market by Type
Figure 9 Global Diabetic Retinopathy Market, by Type, 2022 & 2032 (USD Billion)
Figure 10 Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 11 Strategic Analysis - Diabetic Retinopathy Market